Transfer pricing (2)
Is RPSM the most appropriate transfer pricing method for multinational companies in the time of COVID-19? Learn about the potential issues here.
Your existing (or pending) advance transfer pricing agreement with tax authorities could be affected by the COVID-19 crisis; here are the issues you should be aware of in the months ahead.
When it comes to intercompany transactions, accounting for COVID-19 could potentially impact your transfer pricing risk. Here’s what to think about before making changes to intercompany service charges.
Business is not “as usual” in the time of COVID-19; here’s why you should review your intercompany agreements now in light of the new reality, and questions to consider when amending.
Transitioning from Research Insight to Capital IQ for Compustat’s market research data? Here are four tips to make the transition successfully.